Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study.

Javier García-AbellánSergio PadillaMarta Fernández-GonzálezJosé A GarcíaVanesa AgullóMaría AndreoSandra RuizAntonio GalianaFelix Gutiérrez Mar Masiá

Published in: Journal of clinical immunology (2021)

Long-COVID is associated with weak anti-SARS-CoV-2 antibody response, severity of illness, and female gender. Late clinical events and persistent symptoms in the medium and long term occur in a significant proportion of patients hospitalized for COVID-19.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
coronavirus disease
ejection fraction
newly diagnosed
chronic kidney disease
mental health
prognostic factors
peritoneal dialysis
patient reported outcomes
sleep quality
patient reported